High-performance liquid chromatography (HPLC) confirms safe blood levels of slow-release bupivacaine nanoparticles.
News|Articles|August 17, 2026
Characterizing Conjugated Therapeutics: Advanced LC-MS Strategies for PQAs, Aggregates and Conjugation Sites
Author(s)SCIEX
Comprehensive characterization of biotherapeutics requires advanced analytical strategies capable of detecting and identifying low-abundant product quality attributes (PQAs), including post-translational modifications, aggregates, sequence variants, and conjugation sites. This eBook presents three technical articles demonstrating advanced LC-MS workflows that achieve up to 10X improvement in MS sensitivity for trace-level detection and confident identification of these challenging attributes.
Related to this article
Nano-liquid chromatography-high-resolution tandem mass spectrometry (nano-LC-HRMS/MS) reveals saliva protein shifts before and after multiple sclerosis therapy.
Max Besenhard explains how hybrid mechanistic and machine learning models can make HPLC method development quicker, more robust and ready for autonomous digital twins.
Ultra-high purity BIP® cylinders aim to give analytical laboratories cleaner baselines and lower detection limits
Polymer sorbent and dual microextraction boost gas chromatography with flame ionization detection (GC-FID) pesticide analysis.
Untargeted liquid chromatography–mass spectrometry (LC–MS) ties job stress in workers to plasma lipid changes.
Ultrahigh-pressure liquid chromatography–quadrupole time-of-flight mass spectrometry (UHPLC–QTOF MS) shows diet shapes honeybee metabolic responses to heat.
Trending on LCGC International
1
Fast Low-Pressure Chiral GC for Pesticides in Wine
2
Industry Roundup: Air Products Advances Gas Chromatography Performance
3
AI/ML Now: Hybrid Machine Learning for Experiment-Efficient HPLC
4
AI/ML Now: Bringing Autonomous Digital Twin Workflows Into the Laboratory
5